Common Contracts
3 similar Securities Purchase Agreement contracts by Fennec Pharmaceuticals Inc., Mri Interventions, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 1st, 2022 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of August 1, 2022, by and among Fennec Pharmaceuticals Inc., a British Columbia corporation (the “Company”), each investor identified on the signature pages hereto (each, an “Investor” and collectively, the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (in such capacity, the “Collateral Agent”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 1st, 2022 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of August 1, 2022, by and among Fennec Pharmaceuticals Inc., a British Columbia corporation (the “Company”), each investor identified on the signature pages hereto (each, an “Investor” and collectively, the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (in such capacity, the “Collateral Agent”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 13th, 2020 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 11, 2020, by and among MRI Interventions, Inc., a Delaware corporation with headquarters located at 5 Musick, Irvine, California 92618 (the “Company”), each investor identified on the signature pages hereto (each, an “Investor” and collectively, the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (in such capacity, the “Collateral Agent”).
